SCHEMBL13407641

SCHEMBL13407641

OC[C@@H]1CNCC[C@@H]1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 14/20 0.53
SLC6A4 P31645 14/20 0.53
SLC6A3 Q01959 10/20 0.53
PRMT5 O14744 1/20 0.51
WDR77 Q9BQA1 1/20 0.51
CYP2D6 P10635 2/20 0.43
KCNH2 Q12809 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SIGMAR1 Q99720 1/20 0.41
HTR1A P08908 1/20 0.40
HTR6 P50406 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13389375 1.00 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13389337 0.86 PRMT5 (0.45) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13389509 0.86 PRMT5 (0.45) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13389890 0.86 PRMT5 (0.45) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13408018 0.82 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13389383 0.82 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13389492 0.81 PRMT5 (0.46) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13389252 0.79 PRMT5 (0.44) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13389517 0.79 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3PRMT5WDR77
SCHEMBL13389569 0.79 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3PRMT5WDR77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705153-B2 Bipiperdine derivatives useful as CCR3 antagonists SCHERING CORPORATION (US) 2010-04-27 US disclosed
EP-1725235-B1 PIPERIDINE DERIVATIVES USEFUL AS CCR3 ANTAGONISTS SCHERING CORP (US) 2009-04-15 EP disclosed